73
Participants
Start Date
September 30, 2013
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Nimodipine
Based upon Investigator Judgement
Nimodipine Microparticles
Based upon Investigator Judgement
Mount Sinai Medical Center, New York
Columbia University, New York
Lenox Hill Hospital, New York
Charles University, Department of Neurosurgery, Prague
University of Maryland Medical Cnter, Baltimore
Duke University Medical Center, Durham
Medical University of South Carolina (MUSC), Charleston
Vanderbilt University, Nashville
The Cleveland Clinic Foundation, Cleveland
Mayfield Clinic Inc, Cincinnati
Rush University Medical Center, Chicago
Barrow Neurological Institute, Phoenix
University of New Mexico, Albuquerque
Oregon Health and Science University, Portland
Ronald Reagan UCLA Medical Center, Los Angeles
Hackensack University Medical Center, Hackensack
Overlook Medical Center, Summit
University of Calgary, Foothills Medical Centre, Calgary
University of Alberta Hospital, Edmonton
St. Michael's Hospital, Toronto
University Health Network - Toronto General Division, Toronto Western Hospital, Toronto
University of Saskatchewan, Royal University Hospital, Saskatoon
Helsinki University Central Hospital, Helsinki
Lead Sponsor
Edge Therapeutics Inc
INDUSTRY